Intelligem

Biotech

Business Model: B2B

About

Biotech specializing in non-absorbable drugs for metabolic diseases

Summary

Intelligem is a Biotech company.

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech

Private Equity·$5.0B·Jun 2017

Simtra BioPharma Solutions

Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...

Bloomington, United States1001–5000Biotech, Manufacturing

Private Equity·$4.3B·Oct 2023

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare

Private Equity·$3.9B·Jan 2019

IVI-RMA

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...

Valencia, Spain5001–10000Biotech, Healthcare

Private Equity·$3.3B·Apr 2022

Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare

Private Equity·$3.0B·Jan 2004

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech

Series A·$3.0B·Jan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

<a href="https://indexed.vc/companies/intelligem"><img src="https://indexed.vc/api/badge/company/intelligem" alt="Intelligem on Indexed.vc" width="260" height="76" /></a>